Clinical Impact of Blood Pressure Control on Clinical Outcome in Atrial fibrillation Patients with Hypertensio

Not Applicable

Conditions: Diseases of the ear and mastoid process

Registration Number: KCT0006055

Lead Sponsor: Inha University Hospital

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot yet recruiting

Sex: All

Target Recruitment: 250

Inclusion Criteria

? Patients aged 19 or older with non-membrane atrial fibrillation
? Patients with hypertension who need medication
*Patients with hypertension who require drug treatment currently follow the guidelines for hypertension treatment of the Korean Society of Hypertension in 2018.
? Patients who have not previously taken antihypertensive drugs
? Patients who agree with the purpose of this study

Exclusion Criteria

? Atrial fibrillation accompanied by severe heart malformation or structural heart disease affected by hemodynamics
? Severe renal dysfunction
? Patients with a history of atrial fibrillation high frequency electrode catheter resection or labyrinth surgery
? Patients with significant mitral valve stenosis (moderate or higher)
? Patients with active internal bleeding
? Patients diagnosed with hypertrophic cardiomyopathy
? Polycystic kidney disease
? Significant comorbid disease
? Patients whose survival period is expected to be less than 1 year
? Patients with drug or alcohol addiction
? Patients diagnosed with stroke within the last 3 months
? Patients judged unsuitable for participation in clinical trials by the judgment of other researchers

Study & Design

Study Type: Interventional Study

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
After the normal sinus rhythm, the patient included in the RCT was analyzed using the retention rate and intention to treat analysis.Including interim analysis of patients who followed up for more than 30 days using per-protocol analysis.

Secondary Outcome Measures

Name	Time	Method
-Blood pressure control (average of self-monitoring blood pressure, average of 24-hour active blood pressure monitoring)-Assessment of the incidence of cerebral infarction, hospitalization, cardiovascular events, mortality, and quality of life (SF-36)